Literature DB >> 6374537

The minimum effective dose of estrogen for prevention of postmenopausal bone loss.

R Lindsay, D M Hart, D M Clark.   

Abstract

In a controlled single blind study to determine the minimal effective dose of estrogen for protection against bone loss, conjugated equine estrogens in doses of 0.625 and 1.25 mg per day were equally effective in reducing bone loss in postmenopausal and oophorectomized women when bone mass was estimated by single-photon absorptiometry or radiogrammetry . Daily dose levels of less than 0.625 mg were essentially ineffective. Fifty percent response level was calculated to be 0.45 mg per day. Concomitant biochemical effects, reduction in urine calcium and hydroxyproline, were compatible with the observed effects on bone mineral.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6374537

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  64 in total

Review 1.  A risk-benefit assessment of estrogen therapy in postmenopausal women.

Authors:  M P Cust; K F Gangar; T C Hillard; M I Whitehead
Journal:  Drug Saf       Date:  1990 Sep-Oct       Impact factor: 5.606

Review 2.  [Principles of estrogen therapy].

Authors:  H P Schneider
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

3.  Combination of automatic HPLC-RIA method for determination of estrone and estradiol in serum.

Authors:  T Yasui; M Yamada; H Kinoshita; H Uemura; N Yoneda; M Irahara; T Aono; S Sunahara; Y Mito; F Kurimoto; K Hata
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

Review 4.  Treatment of osteoporosis: current and future.

Authors:  M D Stone; D J Hosking
Journal:  Ann Rheum Dis       Date:  1991-10       Impact factor: 19.103

Review 5.  Late prevention of hip fractures with hormone replacement therapy.

Authors:  J C Stevenson
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507

6.  Estrogen replacement therapy.

Authors:  J R Higgin
Journal:  Can Fam Physician       Date:  1989-06       Impact factor: 3.275

Review 7.  Estrogens, bone loss and preservation.

Authors:  C Christiansen; R Lindsay
Journal:  Osteoporos Int       Date:  1990-10       Impact factor: 4.507

Review 8.  Alternative strategies for prevention of postmenopausal osteoporosis.

Authors:  R Lindsay
Journal:  Public Health Rep       Date:  1989 Sep-Oct       Impact factor: 2.792

Review 9.  Criteria for successful estrogen therapy in osteoporosis.

Authors:  R Lindsay
Journal:  Osteoporos Int       Date:  1993       Impact factor: 4.507

Review 10.  Osteoporosis prevention and treatment with sex hormone replacement therapy.

Authors:  S Rozenberg; M Kroll; A Pastijn; J Vandromme
Journal:  Clin Rheumatol       Date:  1995-09       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.